Medical research

Positive results for new oral drug for pulmonary hypertension

Living with pulmonary arterial hypertension is challenging, but the chore of treating the rare heart disease may change following promising clinical trial data to be published in the Dec. 24 issue of the New England Journal ...

Medications

Uptravi approved for chronic lung disease

(HealthDay)—Uptravi (selexipag) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension, a disabling lung disease that often leads to death or the need for lung transplant.

Cardiology

Prognostic biomarkers ID'd in pulmonary hypertension

(HealthDay)—Biomarkers have been identified for the risk of lung transplantation and death in patients with pulmonary arterial hypertension (PAH), according to a study published online Oct. 26 in the Annals of the American ...

Medical research

Impotence drug aids treatment of rare lung disease

(HealthDay)—A combination treatment using the erectile dysfunction drug Cialis may greatly reduce death and hospitalization from an incurable lung disease that mainly affects women, a new clinical trial shows.

Overweight & Obesity

Can a new drug brown the fat and trim the obese person?

New research has found that a variant of a drug used to treat pulmonary arterial hypertension prompts weight loss in obese mice. Among mice fed a high-fat diet, those who did not get the medication became obese while medicated ...

page 7 from 11